Sustainable sourcing Cosmo recently partnered with EcoVadis to strengthen responsible sourcing and evaluate suppliers on environmental, social, ethical, and procurement standards. This ESG focus creates an opportunity to offer supplier risk analytics, ESG compliance tooling, and procurement optimization services to Cosmo and its supplier network.

AI diagnostics growth The company focuses on Medtech AI and AI driven diagnostics across GI and dermatology. This presents sales opportunities for AI platforms, imaging analytics, data integration, and cloud deployment services to hospitals, clinics, CROs, and medical device partners seeking AI enabled detection capabilities.

Cloud ready With a tech stack centered on Microsoft Azure, PostgreSQL and continuous delivery, Cosmo appears ready for cloud native data platforms, secure data sharing, and compliant model deployment. Propose offerings in cloud based data platform development, interoperability, data security, and DevOps support to accelerate AI projects.

GI and derm focus Target opportunities in gastrointestinal and dermatology markets including inflammatory bowel disease, colon infections, colorectal cancer prevention, and skin and hair health. Potential customers include healthcare providers and pharma manufacturers; explore pilot projects, partnerships for AI driven diagnostic tools in these verticals.

Growth and partnerships Revenue range and growth capital suggest capacity for research and development collaborations, contract manufacturing, and regional expansion in the UK and EU. Propose co development deals, manufacturing partnerships, licensing of AI diagnostics, and distribution arrangements to scale products quickly.